These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18250926)

  • 21. [Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].
    Koedijk FD; van den Broek I; Stirbu-Wagner I; van Bergen JE
    Ned Tijdschr Geneeskd; 2013; 157(24):A5642. PubMed ID: 23759175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
    Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
    N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annual report of the Australian Gonococcal Surveillance Programme, 2007.
    Australian Gonococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2008 Jun; 32(2):227-31. PubMed ID: 18767421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae.
    Lewis DA
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv47-51. PubMed ID: 24243880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the management of gonorrhea in adults in the United States.
    Newman LM; Moran JS; Workowski KA
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S84-101. PubMed ID: 17342672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Annual report of the Australian Gonococcal Surveillance Programme, 2004.
    Australian Gonococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2005; 29(2):137-42. PubMed ID: 16119761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
    Castor D; Prabhakar P; Furlonge C; Rao A; Brown A; Camara B; Weiss H; Jolly PE
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):987-95. PubMed ID: 11785665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The threat of untreatable gonorrhoea: implications and consequences for reproductive and sexual morbidity.
    Ndowa F; Lusti-Narasimhan M
    Reprod Health Matters; 2012 Dec; 20(40):76-82. PubMed ID: 23245412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004 - implications for treatment.
    Sutrisna A; Soebjakto O; Wignall FS; Kaul S; Limnios EA; Ray S; Nguyen NL; Tapsall JW
    Int J STD AIDS; 2006 Dec; 17(12):810-2. PubMed ID: 17212856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of acute gonorrhea].
    Gilliet F; Eichmann A
    Schweiz Med Wochenschr; 1977 Sep; 107(36):1266-9. PubMed ID: 144315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annual report of the Australian Gonococcal Surveillance Programme, 2006.
    Australian Gonococcal Surveillance Program
    Commun Dis Intell Q Rep; 2007 Jun; 31(2):180-4. PubMed ID: 17724992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.
    Lewis DA; Scott L; Slabbert M; Mhlongo S; van Zijl A; Sello M; du Plessis N; Radebe F; Wasserman E
    Sex Transm Infect; 2008 Oct; 84(5):352-5. PubMed ID: 18596070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonococcal drug resistance and treatment of gonorrhoea in Nairobi.
    Perine PL; Biddle JW; Nsanze H; D'Costa LJ; Osaba AO; Widy-Wirski R
    East Afr Med J; 1980 Apr; 57(4):238-46. PubMed ID: 6771118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonococcal urethritis.
    Harrison WO
    Urol Clin North Am; 1984 Feb; 11(1):45-53. PubMed ID: 6231755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain].
    Orfanos CE; Adler M; Hörnle R; Stadler R; Wagner J
    Hautarzt; 1989 Nov; 40(11):713-7. PubMed ID: 2532631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
    Hovhannisyan G; von Schoen-Angerer T; Babayan K; Fenichiu O; Gaboulaud V
    Sex Transm Dis; 2007 Sep; 34(9):686-8. PubMed ID: 17621247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(46):1041-4. PubMed ID: 12487525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annual report of the Australian Gonococcal Surveillance Programme, 2008.
    ; Tapsall J
    Commun Dis Intell Q Rep; 2009 Sep; 33(3):268-74. PubMed ID: 20047199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectinomycin (Trobicin), a new antibiotic for the treatment of gonorrhea.
    Savage GM
    Int J Clin Pharmacol; 1972 Jun; 6(2):143-9. PubMed ID: 4264335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.